Cancer drug deal
Drug maker Bristol Myers Squibb Co. said on Tuesday it wanted to restructure its cancer drug development deal with ImClone Systems Inc., to include the ouster of ImClone's senior management. At the
Drug maker Bristol Myers Squibb Co. said on Tuesday it wanted to restructure its cancer drug development deal with ImClone Systems Inc., to include the ouster of ImClone's senior management. At the